Status
Conditions
Treatments
About
Human induced pluripotent stem cells (iPSCs), are reprogrammed from somatic cells that can self-renew indefinitely and produce different types of cells. They provide human model cell lines for orphan drug development. It is the goal of this study to define new cellular disease models for Inborn Erors of Metabolism, as enabling tools for both drug discovery and development.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
1,000 participants in 1 patient group
Loading...
Central trial contact
Peter Bauer, Prof.
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal